Beranda › Dermatitis Atopik (Eksim) › Florida

Uji klinis Dermatitis Atopik (Eksim) di Florida

18 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical Site 110, Miami

Menerima pesertaFase 1Sukarelawan sehat diterima

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07453602

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

St. Jude Clinical Research- Site Number : 8400049, Doral
Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach

Menerima pesertaStudi observasional

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Miami
Novartis Investigative Site, St. Petersburg

Menerima pesertaFase 2

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Fort Lauderdale
Enveda Investigative Site, Miami
Enveda Investigative Site, Miramar

Menerima pesertaFase 2

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07298395

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Solutions Through Advanced Research, Jacksonville

Menerima pesertaFase 3

Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06807281

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Gsi Clinical Research, Margate

Menerima pesertaFase 2

Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Coral Gables
Investigational Site, Jacksonville
Investigational Site, Margate

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07003425

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Olympian Clinical Research, Tampa

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07223697

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

AllerVie Clinical Research, Panama City
GCP Research , Global Clinical Professionals, St. Petersburg

Menerima pesertaFase 3

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

ABMED Clinical Research Corp., Cape Coral
Skin Care Research, Hollywood
Quality Care Clinical Research, Miami
dan 4 lainnya

Menerima pesertaFase 2

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 19, Ocala
Inmagene Site 4, Tampa

Menerima pesertaFase 2

Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Boca Raton

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07643766

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables

Menerima pesertaFase 3

Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06461897

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Miami Dermatology and Laser Research, Miami

Menerima pesertaFase 1Sukarelawan sehat diterima

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06564389

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Jacksonville
Leo Pharma Investigational site, Miami
Leo Pharma Investigational site, Tampa

Menerima pesertaFase 3

6 Months – 11 Years · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Skin Care Research Boca Raton /ID# 263733, Boca Raton
TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
dan 13 lainnya

Menerima pesertaFase 3

Usia 18 hingga 63 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Revival Research, Doral
Floridian Research Institute Llc, Miami
Global Health Research Center, Inc., Miami Lakes
dan 4 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site 8597, Boca Raton
Galderma Investigational Site 7087, Coral Gables
Galderma Investigational Site 7063, Cutler Bay
dan 7 lainnya

Menerima pesertaStudi observasional

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06988605

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.